- Home
- ADCT vs WSHP Comparison
ADCT vs WSHP Comparison
Compare ADCT & WSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADCT | WSHP |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | Switzerland | British Virgin Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 484.4M | 487.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADCT | WSHP |
|---|---|---|
| Price | $4.37 | $8.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 630.5K | 272.7K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,357,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $66.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.85 | N/A |
| 52 Week Low | $1.14 | $4.95 |
| 52 Week High | $4.98 | $250.00 |
Technical Indicators
Market Signals| Indicator | ADCT | WSHP |
|---|---|---|
| Relative Strength Index (RSI) | 61.38 | 40.90 |
| Support Level | $3.28 | $4.95 |
| Resistance Level | $4.32 | $117.73 |
| Average True Range (ATR) | 0.23 | 1.14 |
| MACD | 0.04 | 1.27 |
| Stochastic Oscillator | 100.00 | 86.47 |
Price Performance
Historical ComparisonAbout ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About WSHP WeShop Holdings Limited Class A Ordinary Shares
WeShop Holdings Ltd is a community owned social commerce platform offering shoppers shares in the Company every time customers make a purchase, recommend a product or refer a new member. WeShop earns revenues from advertising on their platform and commissions on the sales through the platform.